Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

All GLG News Analyses Filed Under: Business of Medicine

Articles with lock require a GLG News subscription
Posted May 15, 2008
Production techniques cause unsafe heparin to be spread through the world resulting in mortality
Analysis of: U.S. Identifies Tainted Heparin in 11 Countries | www.nytimes.com
Author: GLG Member Program Contributor
The issues are several: A wave of disease infected and killed many Chinese pigs (whose intestines are raw source material for heparin) and this drove up prices while decreasing supply. Heparin is a low cost, generic drug requiring an extremely tight supply chain to keep costs down.  ...
Posted May 15, 2008
Reverse Payments for PHRMA smell fishy
Analysis of: US trade agency wants to end deals delaying generics | www.reuters.com
Author: Bruce Goldberg, President Pharmacy Express Services, Inc.
Our FTC has gone on record once again stating that the so called "Phrma reverse payments" to generic manufacturers breach antitrust regulations. Delaying competition by simply paying off another supplier, leads to higher prices for me, you, and our families.  My grandpa used to call this stuff...
Posted May 14, 2008
EHR is way too expensivce and unaffordable for the majority of Physicians
Analysis of: EHR Is Inevitable | www.eclinicalworks.com
Author: GLG Member Program Contributor
EHR should not be mandated unless the government steps in and picks up the majority of the costs to implement and maintain EHR in a physician practice. 
Posted May 12, 2008
More bad news for Merck
Analysis of: Merck Receives Not Approvable Letter from FDA for MK-0524A (ER niacin/laropiprant) | www.pipelinereview.com
Author: GLG Member Program Contributor
Meerck at this point has no major Cardiovascular contentender without issue. This is clearly bad for the company.
Posted May 12, 2008
The Feds Get Personal with your Medical Records
Analysis of: Medicare PHR Pilot is Underway in South Carolina | www.govhealthit.com
Author: GLG Member Program Contributor
Medicare has launched a pilot online personal health records program in South Carolina.  This programs provides thousands of Medicare beneficiaries access to personal health records (PHRs) containing their hospital and physician claims information.  Although information on their prescription...
Posted May 9, 2008
Early Alarms bells missed here, Outsourcing Strategies at Catastrophic Risk
Analysis of: Lawmakers Fault FDA on Heparin | online.wsj.com
Author: GLG Member Program Contributor
Issue: Risk of fraud motivated contamination, and vendor quality failures, could and should have been seen long in advance, and nearly every drug and device faces this threat.  Outsourcing Managers have been entirely cost driven, without exercising adequate management of supply chain...
Posted May 8, 2008
Not the Utility One Might Expect
Analysis of: Physician report card validity | physiciansnews.com
Author: GLG Member Program Contributor
Physician ranking systems will certainly be a part of medical practice. But the real utility is not going to be in allowing patients to choose the "best" doctors--that will perpetuate the fallacy of drawing conclusions about a specific case from the general data. And the ability of this information...
Posted May 8, 2008
Ranking Doctors and Hospitals
Analysis of: Physician report card validity | physiciansnews.com
Author: GLG Member Program Contributor
Ranking doctors and hospitals will certainly move the most profitable patients able to afford commercial health insurance AND travel.  Medical Providers who help set their (local) standards to affect real outcomes reporting regular consumers can understand will increase their market share. ...
Adam Fein Posted May 8, 2008
Analysis of Wal-Mart's Generics Plan
Analysis of: Wal-Mart expands low-price drug program | ap.google.com
Author: Adam Fein, Founder & President Pembroke Consulting Inc
Wal-Mart Stores (WMT) latest expansion of its generic drug program represents more of the same despite the company's promise on Friday to make a “major health care announcement.” Nonetheless, the company’s latest comments shed additional light on the true economics of the program. Here are some high...
Posted May 6, 2008
Interesting Transaction
Analysis of: Esperion Therapeutics Completes $22.75 M Series A Financing | www.pipelinereview.com
Author: GLG Member Program Contributor
Pfizer attempts to leverage their original purchase by a sale of assets and retention of portions of the Esperion assets.  They appear to be retaining a portion of the research of the company while divesting the remaining technology.  They are keeping a small equity position in Esperion...
Previous Page : 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 Next221 to 230 of 649

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-05T05:45:18.353